Gessler M - Search Results

1

Target genes of the WNT/beta-catenin pathway in Wilms tumors.

Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, Graf N, Gessler M. Zirn B, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2006 Jun;45(6):565-74. doi: 10.1002/gcc.20319. Genes Chromosomes Cancer. 2006. PMID: 16575872

2

Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.

Gessler M, König A, Moore J, Qualman S, Arden K, Cavenee W, Bruns G. Gessler M, et al. Genes Chromosomes Cancer. 1993 Jul;7(3):131-6. doi: 10.1002/gcc.2870070304. Genes Chromosomes Cancer. 1993. PMID: 7687865

3

Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters.

Klamt B, Schulze M, Thäte C, Mares J, Goetz P, Kodet R, Scheulen W, Weirich A, Graf N, Gessler M. Klamt B, et al. Among authors: gessler m. Genes Chromosomes Cancer. 1998 Aug;22(4):287-94. doi: 10.1002/(sici)1098-2264(199808)22:4<287::aid-gcc4>3.0.co;2-r. Genes Chromosomes Cancer. 1998. PMID: 9669666

4

Characterization of hey bHLH genes in teleost fish.

Winkler C, Elmasri H, Klamt B, Volff JN, Gessler M. Winkler C, et al. Among authors: gessler m. Dev Genes Evol. 2003 Nov;213(11):541-53. doi: 10.1007/s00427-003-0360-6. Epub 2003 Oct 31. Dev Genes Evol. 2003. PMID: 14593478

5

Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development.

Zirn B, Wittmann S, Graf N, Gessler M. Zirn B, et al. Among authors: gessler m. Cancer Lett. 2005 Mar 18;220(1):115-20. doi: 10.1016/j.canlet.2004.08.001. Cancer Lett. 2005. PMID: 15737694

6

All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.

Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, Gessler M. Zirn B, et al. Among authors: gessler m. Oncogene. 2005 Aug 4;24(33):5246-51. doi: 10.1038/sj.onc.1208725. Oncogene. 2005. PMID: 15897880

7

Novel familial WT1 read-through mutation associated with Wilms tumor and slow progressive nephropathy.

Zirn B, Wittmann S, Gessler M. Zirn B, et al. Among authors: gessler m. Am J Kidney Dis. 2005 Jun;45(6):1100-4. doi: 10.1053/j.ajkd.2005.03.013. Am J Kidney Dis. 2005. PMID: 15957141

8

Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters.

Zirn B, Hartmann O, Samans B, Krause M, Wittmann S, Mertens F, Graf N, Eilers M, Gessler M. Zirn B, et al. Among authors: gessler m. Int J Cancer. 2006 Apr 15;118(8):1954-62. doi: 10.1002/ijc.21564. Int J Cancer. 2006. PMID: 16287080

9

Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array.

Benetkiewicz M, Díaz de Ståhl T, Gördör A, Pfeifer S, Wittmann S, Gessler M, Dumanski JP. Benetkiewicz M, et al. Among authors: gessler m. Int J Cancer. 2006 Aug 1;119(3):571-8. doi: 10.1002/ijc.21868. Int J Cancer. 2006. PMID: 16496407

10

Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.

Wittmann S, Zirn B, Alkassar M, Ambros P, Graf N, Gessler M. Wittmann S, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2007 Feb;46(2):163-70. doi: 10.1002/gcc.20397. Genes Chromosomes Cancer. 2007. PMID: 17099873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters